A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice

Cell Res. 2020 Oct;30(10):936-939. doi: 10.1038/s41422-020-00392-7. Epub 2020 Aug 17.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Betacoronavirus / genetics*
  • Betacoronavirus / immunology
  • COVID-19
  • COVID-19 Vaccines
  • Coronavirus Envelope Proteins
  • Coronavirus Infections / genetics
  • Coronavirus Infections / immunology
  • Coronavirus Infections / prevention & control*
  • HEK293 Cells
  • Humans
  • Immunity, Cellular
  • Immunity, Humoral
  • Immunization
  • Mice
  • Pandemics / prevention & control*
  • Pneumonia, Viral / immunology
  • Pneumonia, Viral / prevention & control*
  • RNA, Messenger / genetics
  • RNA, Messenger / pharmacology
  • RNA, Messenger / therapeutic use*
  • SARS-CoV-2
  • Spike Glycoprotein, Coronavirus / genetics
  • Spike Glycoprotein, Coronavirus / immunology
  • Vaccines, Virus-Like Particle / genetics
  • Vaccines, Virus-Like Particle / pharmacology
  • Vaccines, Virus-Like Particle / therapeutic use*
  • Viral Envelope Proteins / genetics
  • Viral Envelope Proteins / immunology
  • Viral Matrix Proteins / genetics
  • Viral Matrix Proteins / immunology
  • Viral Vaccines / genetics
  • Viral Vaccines / pharmacology
  • Viral Vaccines / therapeutic use*

Substances

  • COVID-19 Vaccines
  • Coronavirus Envelope Proteins
  • RNA, Messenger
  • Spike Glycoprotein, Coronavirus
  • Vaccines, Virus-Like Particle
  • Viral Envelope Proteins
  • Viral Matrix Proteins
  • Viral Vaccines
  • envelope protein, SARS-CoV-2
  • membrane protein, SARS-CoV-2
  • spike protein, SARS-CoV-2